Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,713 evidence items · page 53 / 69

74.48 %Shifting to MALDI-TOF MS for malaria vector surveillance would result in a 74.48% net time saving.

Kenyapaludismepublished 2025PloS onePubMeddocument of 5 observations

21.02 %Blood group B prevalence among the enrolled individuals was 21.02%.

Kenyapaludismepublished 2022Malaria journalPubMeddocument of 23 observations

1,300,000 childrenRisks of infection with Plasmodium falciparum among Kenyan children were estimated as stable but low for 1.3 million.

Kenyapaludismepublished 1998Annals of tropical medicine and parasitologyeurope_pmcdocument of 5 observations

2.27 ORCompliance with withholding anti-malarial treatment for test-negative patients increased annually in low risk areas of Kenya with an odds ratio of 2.27.

Kenyapaludismepublished 2020Malaria journaleurope_pmcdocument of 9 observationsDOI 10.1186/s12936-020-03479-z

50.4 %The proportion of PCR-positive Plasmodium infections that were submicroscopic increased from 50.4% to 80.7% over the study period in Homa Bay County, Kenya.

Kenyapaludismepublished 2022Malaria journalPubMeddocument of 8 observations

100 %The treatment outcome for the 41 positive patients was 100% Adequate Clinical and Parasitological Response (ACPR).

Kenyapaludismepublished 2025Malaria journalPubMeddocument of 9 observations

Male sex was associated with increased risk of submicroscopic malaria infection (p = 0.025).

Kenyapaludismepublished 2022PloS onePubMeddocument of 15 observations

92.2 %Rapid diagnostic tests registered a sensitivity of 92.2% for Plasmodium falciparum infection in children.

Kenyapaludismeobserved 2014published 2019Wellcome open researcheurope_pmcdocument of 6 observations

1,000,000,000 US dollarsAlmost US$1 billion in international funding is distributed each year to the 1.4 billion people exposed to stable Plasmodium falciparum malaria risk.

Kenyapaludismepublished 2008PLoS medicineeurope_pmcdocument of 5 observations

Episodes of clinical malaria were recorded in a population from 2007 to 2017.

Kenyapaludismeobserved 2007 to 2017published 2025Malaria journalPubMeddocument of 8 observations

76 %The monthly testing positivity rate (TPR) reduced from 46% in February 2016 to 11% in February 2018 in the intervention area, representing a 76% absolute decrease in TPR among all ages.

Kenyapaludismeobserved February 2016 to February 2018published 2022PloS onePubMeddocument of 6 observations

1,676 KShThe total household cost per patient admitted with a malaria diagnosis was KSh 1676 (USD 16.4).

Kenyapaludismeobserved June 2016 to May 2017published 2021Malaria journalPubMeddocument of 11 observations

39 %Overall, service-based malaria vaccine coverage was 39% for dose 4 of RTS,S/AS01 in Kenya's pilot implementation.

Kenyapaludismeobserved 2019-2022published 2023Malaria journaleurope_pmcdocument of 10 observations

Malaria mortality showed spatial variation that peaked every May-June in western Kenya between 2008 and 2019.

Kenyapaludismeobserved 2008–2019published 2024BMJ global healthPubMeddocument of 8 observations

The incidence of both uncomplicated and severe P. falciparum malaria was close to baseline in children heterozygous with respect to the mutation underlying the hemoglobin S variant and homozygous with respect to the mutation underlying alpha(+)-thalassemia.

Kenyapaludismepublished 2005Nature geneticseurope_pmcDOI 10.1038/ng1660

58.8 %IPTp₃+ coverage was 58.8% among pregnancies not exposed to extreme weather events.

Kenyapaludismepublished 2026Malaria journalPubMed

0.56 odds_ratioThe presence of antibodies to LSA-1 was associated with decreased odds of developing clinical malaria (odds ratio 0.56, 95% CI 0.36–0.89).

Kenyapaludismepublished 2020The American journal of tropical medicine and hygienePubMeddocument of 6 observations

70.18 %The double mutant SGEAA haplotype in Pfdhps had a prevalence of 70.18% in Kisumu and 51.06% in Kisii.

Kenyapaludismepublished 2025Malaria journalPubMeddocument of 14 observations

57.42 %After 12 months of outdoor exposure, the mouldiest ATSBs from exposed locations showed a non-significant reduction in Anopheles arabiensis feeding rates compared to the least mouldy ATSBs from protected locations: 57.42% vs. 74.40%.

Kenyapaludismeobserved 12 monthspublished 2025PloS onePubMeddocument of 3 observations

80 %The uptake of malaria preventive measures is still below 80% for both ITN and IPTpSP during pregnancy in Kenya.

Kenyapaludismepublished 2022Malaria journaleurope_pmcdocument of 5 observationsDOI 10.1186/s12936-022-04425-x

19.7 %441 out of 2239 (19.7%) children with severe malaria had severe respiratory distress.

Kenyapaludismepublished 2020Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 15 observationsDOI 10.1093/cid/ciz844

2.33 AORThe odds of taking three or more doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy increased by a factor of 2.33 among women with high decision-making autonomy, after controlling for individual characteristics and number of antenatal care visits.

Kenyapaludismepublished 2023Malaria journalPubMeddocument of 3 observations

74 %The Dantu blood group antigen is associated with 74% protection against severe and complicated P. falciparum malaria infections in homozygous individuals.

Kenyapaludismepublished 2022Controlled Human Malaria Infection reveals that the Dantu blood group variant provides higeurope_pmcdocument of 6 observationsDOI 10.1101/2022.09.21.22280031

First-trimester malaria was associated with increased prevalence of anemia later in pregnancy.

Kenyapaludismepublished 2024PloS onePubMeddocument of 14 observations

88.2 %In a cross-sectional study conducted in April 2024 in Kanyamwa Kologi Ward in Homa Bay County, Kenya, the overall proportion of households that reported at least one child had received one dose of the RTS,S malaria vaccine was 88.2%.

Kenyapaludismeobserved April 2024published 2025Malaria journalPubMeddocument of 4 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.